Harvard Bioscience Inc.

NASDAQ: HBIO · Real-Time Price · USD
0.48
-0.05 (-9.06%)
At close: Aug 11, 2025, 3:59 PM

Harvard Bioscience Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-7.41 -66.46 -12.05 -987.56
PEG Ratio
-0.03 1.02 -0.00 10.24
PS Ratio
0.98 2.02 1.01 2.39
PB Ratio
1.45 3.11 1.59 3.41
P/FCF Ratio
-76.3 19.37 -261.9 -3.43K
P/OCF Ratio
63.80 16.18 99.58 225.37
OCF/S Ratio
0.02 0.12 0.01 0.01
Debt / Equity Ratio
0.70 0.59 0.65 0.58
Quick Ratio
0.40 0.92 1.06 1.34
Current Ratio
0.82 1.85 2.20 2.43
Asset Turnover
0.74 0.82 0.78 0.73
Interest Coverage
-1.94 0.53 -2.81 0.91
Return on Equity
-0.2 -0.05 -0.13 n/a
Return on Assets
-0.1 -0.02 -0.07 n/a
Return on Invested Capital
-0.06 0.02 -0.06 0.02
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.58 0.59 0.54 0.57
Net Profit Margin
-0.13 -0.03 -0.08 -0.00
Pretax Profit Margin
-0.12 -0.02 -0.08 -0.00
Operating Profit Margin
-0.07 0.02 -0.06 0.01
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.02 0.07 0.01 0.10